PP2A Is Required for B Cell Survival and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

被引：4
|
作者：
Gang, Xiao [1 ]
Geng, Huimin [2 ]
Chan, Lai N. [1 ]
Chen, Zhengshan [1 ]
Jiang, Xiaoyan [3 ]
Muschen, Markus [1 ]
机构：
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Lab Med, San Francisco, CA 94143 USA
[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.3900.3900
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PHENOTHIAZINE ANTIPSYCHOTICS ACTIVATE THE PP2A TUMOR SUPPRESSOR FOR THERAPEUTIC ACTIVITY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Gutierrez, Alejandro
    Pan, Li
    Kentsis, Alex
    Marineau, Jason
    Grebliunaite, Ruta
    Kozakewich, Elena
    Reed, Casie
    Bradner, James
    Aster, Jon
    Look, A. Thomas
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1035 - 1035
  • [2] Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
    Shojaee, Seyedmehdi
    Caeser, Rebecca
    Buchner, Maike
    Park, Eugene
    Swaminathan, Srividya
    Hurtz, Christian
    Geng, Huimin
    Chan, Lai N.
    Klemm, Lars
    Hofmann, Wolf-Karsten
    Qiu, Yi Hua
    Zhang, Nianxiang
    Coombes, Kevin R.
    Paietta, Elisabeth
    Molkentin, Jeffery
    Koeffler, H. Phillip
    Willman, Cheryl L.
    Hunger, Stephen P.
    Melnick, Ari
    Kornblau, Steven M.
    Mueschen, Markus
    CANCER CELL, 2015, 28 (01) : 114 - 128
  • [3] Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia
    Hiroaki Goto
    Yuki Yoshino
    Mieko Ito
    Junichi Nagai
    Tadashi Kumamoto
    Takesi Inukai
    Yukari Sakurai
    Naoyuki Miyagawa
    Dai Keino
    Tomoko Yokosuka
    Fuminori Iwasaki
    Satoshi Hamanoue
    Masae Shiomi
    Shoko Goto
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 773 - 783
  • [4] Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia
    Goto, Hiroaki
    Yoshino, Yuki
    Ito, Mieko
    Nagai, Junichi
    Kumamoto, Tadashi
    Inukai, Takesi
    Sakurai, Yukari
    Miyagawa, Naoyuki
    Keino, Dai
    Yokosuka, Tomoko
    Iwasaki, Fuminori
    Hamanoue, Satoshi
    Shiomi, Masae
    Goto, Shoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 773 - 783
  • [5] Erk and Stat5 Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
    Seyedmehdi, Shojaee
    Chen, Zhengshan
    Buchner, Maike
    Hurtz, Christian
    Geng, Huimin
    Schjerven, Hilde
    Chan, Lai N.
    Koeffler, Phillip
    Willman, Cheryl L.
    Hunger, Stephen
    Dovat, Sinisa
    Paietta, Elisabeth
    Hofmann, Wolf-Karsten
    Melnick, Ari M.
    Alexander, Warren S.
    Kornblau, Steven M.
    Muschen, Markus
    BLOOD, 2014, 124 (21)
  • [6] BCL-2, a Therapeutic Target for High Risk Hypodiploid B-Cell Acute Lymphoblastic Leukemia
    Diaz-Flores, Ernesto
    Comeaux, Evan Q.
    Kim, Kailyn
    Beckman, Kyle
    Davis, Kara L.
    Wu, Kevin
    Akutagawa, Jon
    Holmfeldt, Linda
    Braun, Benjamin S.
    Mullighan, Charles
    Loh, Mignon L.
    BLOOD, 2016, 128 (22)
  • [7] Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia
    Hiroaki Goto
    Yuki Yoshino
    Mieko Ito
    Junichi Nagai
    Tadashi Kumamoto
    Takesi Inukai
    Yukari Sakurai
    Naoyuki Miyagawa
    Dai Keino
    Tomoko Yokosuka
    Fuminori Iwasaki
    Satoshi Hamanoue
    Masae Shiomi
    Shoko Goto
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 1055 - 1056
  • [8] The PP2A Subunit B55α Suppresses Survival Signaling in Acute Myeloid Leukemia Cells
    Ruvolo, Peter P.
    Ruvolo, Vivian
    Zeng, Zhihong
    Qui, YiHua
    Zhou, Liran
    Gallagher, Kelly E.
    Konopleva, Marina
    Kornblau, Steven M.
    Andreeff, Michael
    BLOOD, 2011, 118 (21) : 182 - 182
  • [9] FOXM1 Mediates Drug-Resistance and Represents a Therapeutic Target in Pre-B Acute Lymphoblastic Leukemia
    Buchner, Maike
    Park, Eugene
    Klemm, Lars
    Geng, Huimin
    Kopanja, Dragana
    Raychaudhuri, Pradip
    Muschen, Markus
    BLOOD, 2014, 124 (21)
  • [10] SYK Is a Tumor Suppressor In Pre-B Cell Acute Lymphoblastic Leukemia and Not a Therapeutic Target
    Ng, Carina
    Nahar, Rahul
    Elliott, Emily
    Lowell, Clifford A.
    Muschen, Markus
    BLOOD, 2010, 116 (21) : 1706 - 1707
12345